Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
Now available on-demand! Cracking the code: learnings from oligonucleotide method development WATCH NOW

Infographic: HRMS in DMPK

28 Nov 2019
General interest

As part of our Spotlight on HRMS, we carried out a survey to gain an insight into the trends, challenges and developments associated with the use of HRMS for DMPK studies. We would like to thank everyone who was able to share their thoughts by taking part in the survey – you can see the results below in our infographic.

HRMS in DMPK spotlight infographic_NM-01-min

< Back to – Spotlight: HRMS in DMPK

Top content

  • Valneva withdraws US applications for Chikungunya vaccine IXCHIQ®
  • Deeper than the definition: redux edition
  • A new standard in mass-spectrometry-based proteomics

Related tags

DMPK HRMS infographic QQQ Survey
Previous article Next article

Related articles

19 DEC 2013 JOURNAL ARTICLES
Validation of hepcidin quantification in plasma using LC-HRMS and discovery of a new hepcidin isoform
6 OCT 2017 SMALL MOLECULES
Spotlight survey on emerging technologies: DMPK and bioanalysis of small molecules
13 NOV 2018 IMMUNOGENICITY
Immunogenicity infographic
14 OCT 2019 GENERAL INTEREST
Complexity of human diseases should promote the use of high-resolution mass spectrometry for routine untargeted analyses
10 APR 2019 ADVANCED THERAPIES
Cell and gene therapy infographic
2 MAR 2018 MS (LC–MS/MS, HRMS, IMS)
1. What molecules do you predominantly work with, and (how/why) do you use HRMS for their analysis?
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone